That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.
Any enterprise centered on the processing, assembly, production, or marketing of a line of products, services, commodities, or merchandise, in a particular field often named after its principal product. Examples include the automobile, fishing, music, publishing, insurance, and textile industries.
The aggregate business enterprise of agriculture, manufacture, and distribution related to tobacco and tobacco-derived products.
The industry concerned with processing, preparing, preserving, distributing, and serving of foods and beverages.

Revolving drug funds: a step towards health security. (1/1252)

The establishment of a revolving drug fund project in Viet Nam is described and the factors responsible for its success are considered. As well as being a tool for cost recovery a revolving drug fund can serve as an entry point for strengthening health care and improving health security at local and district level.  (+info)

Sales practices of patent medicine sellers in Nigeria. (2/1252)

A survey was carried out among patent medicine dealers to evaluate their practices that militate against laws governing prescriptions-only medicines in Nigeria. Questionnaires were distributed to 46 patent medicine dealers and later collected from them on appointment. Analysis of the results showed that all the patent medicine dealers were aware of the law governing the sale of prescription drugs in Nigeria. Seventy-five per cent of them stock such drugs. Patent medicine dealers obtain their drugs largely from sales representative of pharmaceutical companies as well as from industries. Inappropriate use of sales boys and girls in patent medicine stores and defective government policies were all investigated.  (+info)

Hospitals and managed care: catching up with the networks. (3/1252)

Although the growth of managed care is having a significant impact on hospitals, organizational response to managed care remains fragmented. We conducted a survey of 83 hospitals nationwide that indicated that most hospitals now have at least one person devoted to managed care initiatives. These individuals, however, often spend most of their time on current issues, such as contracting with managed care organizations and physician relations. Concerns for the future, such as network development and marketing, although important, receive less immediate attention form these individuals. Hospital managed care executives must take a more proactive role in long range managed care planning by collaborating with managed care organizations and pharmaceutical companies.  (+info)

The challenge of integrating monoclonal antibodies into the current healthcare system. (4/1252)

Although there are few monoclonal antibody (MoAb) products on the market, the biotechnology industry has made considerable progress over the last decade. The industry has developed new technology to address the primary hurdles facing the development of MoAbs--including the immune response to murine-derived antibodies as well as lack of tumor specificity. As the techniques for development become more refined, more products will be approved by the Food and Drug Administration. Integrating these products into the existing healthcare system will be a challenge, given their high acquisition costs. Recent pharmacoeconomic examples outlined in this paper confirm that MoAb products will need to be supported with proven clinical and economic profiles. As long as a global clinical and economic perspective is taken and patient care benefits can be demonstrated, the place of MoAbs in the future of healthcare will be assured.  (+info)

Sale of drugs and health care utilization in a health care district in Zaire. (5/1252)

Health centres of Idjwi district (Zaire) have been self-financed through the selling of drugs since 1985. Medical care is expensive and its use is low (24 visits per year per 100 inhabitants). In 1989 the medical team tried to reduce the cost of visits by changing the prices of drugs and prescriptions. A limited control was set up to assess this intervention. The study showed that although prescribed drug costs were stabilized compared to inflation, there was no increase in the use of medical care. Moreover, the reduction of drug profit margins for health centres seriously affected the health care institution by causing a drop in income. Six months after the intervention the monthly accounts showed a deficit in 6 centres out of 8. The need for health care centres to be self-financing is a major limiting factor in the use of health care in Idjwi district. There are no easy solutions for health centre managers that satisfy both low-cost access to care and health care self-financing. Some minimal financial participation from the state is required. Only then can the concept of financing health care through the selling of drugs be operational.  (+info)

Managed care guidelines for the economic evaluation of pharmaceuticals. (6/1252)

Foundation Health Corporation, through its National Pharmacy and Therapeutics Committee, requires all pharmaceutical manufacturers and others who wish products to be considered for formulary listing to meet evidentiary and analytical standards in their submission documentation. This article details the evidentiary and analytical standards required from those making submissions and describes the methodological basis of the guidelines. This is the first time, as far as the authors are aware, that a managed care health system in the United States has required formulary submissions not only to meet clinical and economic evaluation standards, but also to take explicit account of the perspective of the managed care group in applying these techniques. Submissions are required to take what is described as a systems impact perspective. This approach is quite different, in both evidentiary and analytical terms, from standards required by health systems in other countries and standards for the economic evaluation of pharmaceuticals proposed by expert groups in the United States.  (+info)

Three countries' experience with Norplant introduction. (7/1252)

Despite international efforts to plan for Norplant introduction, the method has drawn the attention of critics of family planning programmes, and has raised several issues for debate since it was introduced into family planning programmes. The experiences of three countries with the introduction of Norplant highlight some of the unique features of the method that have affected its introduction. Indonesia, Bangladesh and the United States represent diverse cultural settings and systems of family planning provision. Experience in each country has highlighted the need to focus on quality of care for clients, most notably the need for good counselling and attention to removal as well as insertion. The cost of Norplant also has influenced its introduction in each country. Another issue includes the need to work with women's health advocacy groups, which is illustrated particularly in Bangladesh. Finally, the role of litigation in the United States, and its potential role in influencing Norplant introduction in other countries, is discussed. These three countries' experience illustrate the importance of understanding the programmatic context of contraceptive introduction.  (+info)

Outcomes research: collaboration among academic researchers, managed care organizations, and pharmaceutical manufacturers. (8/1252)

Medical and pharmaceutical outcomes research has been of increasing interest in the past 10 to 15 years among healthcare providers, payers, and regulatory agencies. Outcomes research has become a multidisciplinary field involving clinicians, health services researchers, epidemiologists, psychometricians, statisticians, psychologists, sociologists, economists, and ethicists. Collaboration among researchers in different organizations that offer different types of services and various research expertise is the essential element for any successful outcomes project. In this article we discuss collaboration on outcomes research among academic researchers (mainly those who work in colleges of pharmacy), managed care organizations, and research-based pharmaceutical manufacturers, with a focus on the opportunities and challenges facing each party. The pharmaceutical industry needs information to make product and promotion decisions; the managed care industry has data to offer but needs analysis of these data; and pharmacy schools, among other academic institutions, have skilled researchers and data-processing capacity but require projects for revenue, research training, experience, and publications. Challenges do exist with such endeavors, but collaboration could be beneficial in satisfying the needs of the individual parties.  (+info)

The "drug industry" is also commonly referred to as the "pharmaceutical industry." It is a segment of the healthcare sector that involves the research, development, production, and marketing of medications or drugs. This includes both prescription and over-the-counter medicines used to treat, cure, or prevent diseases and medical conditions in humans and animals.

The drug industry comprises various types of organizations, such as:

1. Research-based pharmaceutical companies: These are large corporations that focus on the research and development (R&D) of new drugs, clinical trials, obtaining regulatory approvals, manufacturing, and marketing their products globally. Examples include Pfizer, Johnson & Johnson, Roche, and Merck.

2. Generic drug manufacturers: After the patent for a brand-name drug expires, generic drug manufacturers can produce and sell a similar version of the drug at a lower cost. These companies must demonstrate that their product is bioequivalent to the brand-name drug in terms of safety, quality, and efficacy.

3. Biotechnology companies: These firms specialize in developing drugs using biotechnological methods, such as recombinant DNA technology, gene therapy, or monoclonal antibodies. Many biotech companies focus on specific therapeutic areas, like oncology, immunology, or neurology.

4. Contract research organizations (CROs): CROs provide various services to the drug industry, including clinical trial management, data analysis, regulatory affairs support, and pharmacovigilance. They work with both large pharmaceutical companies and smaller biotech firms to help streamline the drug development process.

5. Drug delivery system companies: These organizations focus on developing innovative technologies for delivering drugs more effectively and safely to patients. Examples include transdermal patches, inhalers, or long-acting injectables.

6. Wholesalers and distributors: Companies that purchase drugs from manufacturers and distribute them to pharmacies, hospitals, and other healthcare providers.

The drug industry plays a crucial role in improving public health by discovering, developing, and delivering new treatments for various diseases and medical conditions. However, it is also subject to criticism and regulation due to concerns about high drug prices, marketing practices, and the potential for conflicts of interest between industry and healthcare professionals.

I believe there may be some confusion in your question. "Industry" is a general term that refers to a specific branch of economic activity, or a particular way of producing goods or services. It is not a medical term with a defined meaning within the field of medicine.

However, if you are referring to the term "industrious," which can be used to describe someone who is diligent and hard-working, it could be applied in a medical context to describe a patient's level of engagement and effort in their own care. For example, a patient who is conscientious about taking their medications as prescribed, following through with recommended treatments, and making necessary lifestyle changes to manage their condition might be described as "industrious" by their healthcare provider.

A Tobacco Industry is a commercial sector involved in the cultivation, production, manufacturing, marketing, and distribution of tobacco and tobacco-related products. This can include growers who produce tobacco leaves, manufacturers who process the leaves into various forms (such as cigarettes, chewing tobacco, or snuff), and companies that market and distribute these products to consumers. It is important to note that the tobacco industry has been associated with significant health risks, as the use of tobacco products can lead to a range of serious health problems, including cancer, heart disease, and lung disease.

I'm sorry for any confusion, but "Food Industry" is not a term that has a medical definition. The food industry is a broad category that includes businesses involved in the production, processing, packaging, distribution, and sale of food products. This can include farms, fisheries, manufacturers of food products, grocery stores, restaurants, and more.

If you have any questions related to nutrition or dietary habits and their impact on health, I would be happy to help provide information based on medical knowledge.

The Drug Industry Documents Archive (DIDA) is a digital archive of pharmaceutical industry documents created and maintained by ... Wyeth paid medical ghostwriters to author journal articles about the drug. "About the Project". Drug Industry Document Archive ... The UCSF_Library created this digital archive in an attempt to facilitate further research into the drug industry's practice of ... DIDA is a part of the larger UCSF Industry Documents Library which includes the Truth Tobacco Industry Documents. The archive ...
The plaintiff, Hemp Industries Association (HIA) claimed that CBD is not regulated by the Controlled Substances Act; the Drug ... Hemp Industries Association v. Drug Enforcement Administration, often shortened to HIA v. DEA, refers to two lawsuits ... "DEA seeks dismissal of hemp industry lawsuit fighting drug code for "marihuana extracts"". Hoban Law Group. January 13, 2017. ... Aleta Labak (June 2, 2017), "DEA seeks dismissal of hemp industry lawsuit fighting drug code for "marihuana extracts"", The ...
... led a series of hearings enquiring about the pharmaceutical industry's motive to produce me-too drugs after it was noted that ... The term "me-too drug" or "follow-on drug" refers to a medication that is similar to a pre-existing drug, usually by making ... existing drugs" "a drug with a similar chemical structure or the same mechanism of action as a drug that is already marketed". ... drugs without signal advantage of any sort". Once a new drug class was discovered, other major drug companies made efforts to ...
Bharadwaj, K. v Aditya; Gowhar, Imran (2020-09-19). "Kannada film industry and drugs , Cracking the world of make-believe". The ... "At Least 15 In Kannada Film Industry Into Drug Trade, Claims Filmmaker". NDTV.com. Retrieved 2020-09-10. "Kannada actor ... They were suspected of buying drugs from Loum Pepper Samba, an alleged drug peddler from Senegal. The bail pleas of Dwivedi and ... "Expect more surprises in drugs case". Deccan Herald. 2020-09-08. Retrieved 2020-09-09. Swamy, Rohini (2020-09-10). "Drugs, big- ...
David Uren (13 September 2013). "Illegal drugs industry adds $6bn to economy". The Australian. Retrieved 13 September 2013. ... Illicit drug use in Australia is the recreational use of prohibited drugs in Australia. Illicit drugs include illegal drugs ( ... "Support drug law reform". reason.org.au. Retrieved 3 September 2022. Global Commission on Drugs (June 2011). War on Drugs. ... Australian National Council on Drugs Cannabis in Australia Crime in Australia Drug courts in Australia Drug liberalization Drug ...
Drug & Cosmetic Industry. February 1889: 34 Official website AuraSensory.com v t e (Articles with short description, Short ...
500m drug industry revealed". The Guardian. ISSN 0261-3077. Retrieved 29 January 2019. "Drugs trade has 'never caused greater ... County lines': huge scale of £500m drug industry revealed". The Guardian. 29 January 2019. Retrieved 23 April 2021. Charles ... "Illegal drugs 'almost as easy to get as pizza'". BBC News. 27 February 2020. Retrieved 28 February 2020. "Drug dealer who ... In the United Kingdom, the county lines drug supply model is the practice of trafficking drugs into rural areas and smaller ...
"How Drag Race PH's Turing got into drag industry". ABS-CBN. Archived from the original on 2023-06-29. Retrieved 2023-10-15. " ... Turing is a drag performer. She has performed regularly at O Bar. Turing competed on season 1 of Drag Race Philippines. She was ... "Fond of Drag? Get to Know The 12 Queens of Drag Race PH". Tatler Asia. Archived from the original on 2023-10-05. Retrieved 2023 ... Turing (also known as Turing Quinto) is a Filipino drag performer who competed on season 1 of Drag Race Philippines. Turing was ...
"Shining stars: Luminaries in the generics industry". Drug Store News. July 16, 2019. "Newly Merged Amneal Pharmaceuticals to ... In 2007, the company acquired five divested drugs from Mylan which Mylan was forced to sell as part of their acquisition of the ... "How $6 billion generic drug company merger could affect this East Bay city and Roche". San Francisco Business Times. May 9, ... "How $6 billion generic drug company merger could affect this East Bay city and Roche". San Francisco Business Times. May 9, ...
"Bribes tarnish drug industry". Korea JoongAng Daily. Retrieved 6 August 2022. "눈 건강 '토비콤' 아버지 어준선 안국약품 창업주 별세". The Financial ... Chief executives in the pharmaceutical industry, People from North Chungcheong Province, Hamjong Eo clan). ...
"Medical Product Activities During the Federal Government Shutdown". For Industry. Food and Drug Administration. October 8, 2013 ... The FCC stopped work on its approvals of mergers in the telecommunications and broadcast television industries. The list of ... Approximately 45% of the Food and Drug Administration's 14,779 employees were furloughed. The FDA stopped routine food safety ... Drug Administration (FDA) Matters". The National Law Review. Archived from the original on October 21, 2013. Retrieved 2013-10- ...
"About the Project". Drug Industry Documents Archive. Retrieved 18 April 2013. Fugh-Berman, AJ (7 September 2010). "The haunting ... were initially made publicly available on the PLOS Medicine website but they are now available as part of the Drug Industry ... Godlee, F.; Groves, T. (2012). "The new BMJ policy on sharing data from drug and device trials". BMJ. 345: e7888. doi:10.1136/ ... "EMA workshop reveals divisions with industry . ecancer - News". Ecancer.org. 20 December 2012. Retrieved 26 April 2013. " ...
He was a grandson of William Davis Ticknor, founder of the publishing ... "William D. Ticknor". Drug and Cosmetic Industry. ...
"Drug Plants". Drug and Cosmetic Industry. 53 (6): 691-693. 1 December 1943 - via Internet Archive. "United States Aids Mexico ... By the late 1920s Rodríguez was the richest man in Baja California, due to his control over the border vice industry. By the ... Mexico's major contribution to the war effort was a steady supply of raw materials for US industry. Thus, during the war, ... From January 1932 to July 1932 he was Secretary of Industry, Commerce and Labor. From August 1932 to September 1932 he was ...
"Drug Industry Document Archive". dida.library.ucsf.edu/. University of California, San Francisco. March 12, 2012. Retrieved ... It was later found that the article had been ghostwritten by Scientific Therapeutics Information on behalf of the drug company ...
Statisticians in the Pharmaceutical Industry; the Drug Information Association; the Royal Statistical Society; and the ...
... from the drug industry, and that the drug company lobbyists, combined with the politicians who worked on behalf of their ... In 2013 and 2014, generic drug pricing for over 200 drugs increased over 100%. Many of those drugs had price hikes over 1000%. ... Rx R&D Myths: The Case Against The Drug Industry's R&D "Scare Card" (PDF) (Report). Public Citizen. 2001. "Critique of the ... Richard D. Lyons (December 31, 1970). Ousted F.D.A. Chief Charges 'Pressure' From Drug Industry . The New York Times. Retrieved ...
Kwon, Mee-yoo (28 April 2009). "Drug Scandal Jolts Showbiz Industry". The Korea Times. Retrieved 2013-05-25. Chung, Sun-gu; ... No stranger to controversy, Sung was caught for using the drug ecstasy in 2002, and previously published a book containing nude ...
"FDA approves Striverdi Respimat to treat chronic obstructive pulmonary disease". FDA News/Drug Industry Daily. 31 July 2014. ( ... To judge from the drug's mechanism of action and from experiences with related drugs, hypertension (high blood pressure), ... On 29 January 2013 the U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) recommended ... FDA News/Drug Industry Daily. "New once-daily Striverdi (olodaterol) Respimat gains approval in first EU countries". Boehringer ...
Gina Kolata (November 9, 2003). "Ideas & Trends; The Drug Industry's Holy Grail". New York Times. director of medical research ...
Reporter for the Chain Drug Store Industry". Chain Drug Review. 15 May 2013. Archived from the original on 26 August 2014. ... "Chain to review drug charges as huge price gaps uncovered". Irish Independent. 9 July 2011. "Retail Week". October 2013. " ... When the Almus brand was created it was a catalyst for change in the generic medicines industry with its unique colored ... "Alliance Boots: 'Good progress' with Walgreens - Retail News Breaks - Front Page - Chain Drug Review :: ...
Whitaker, Bill (October 15, 2017). "Ex-DEA agent: Opioid crisis fueled by drug industry and Congress". CBS News. Retrieved ... The Ensuring Patient Access and Effective Drug Enforcement Act of 2016 is a United States federal statute enacted by the 114th ... This was purportedly the reason behind Marino's withdrawal of his candidacy for Director of the Office of National Drug Control ... "Tom Marino, Trump's Pick As Drug Czar, Withdraws After Damaging Opioid Report". The Two Way. NPR. October 17, 2017. Retrieved ...
The new millennium saw a boom in the illegal drug industry. In 2010 alone, a U.S. International Narcotics Control Strategy ... Bangladesh drug war Mexican drug war Thailand drug war War on drugs (United States) Extrajudicial killing 2017 Bureau of ... The Philippine drug war, known as the War on Drugs, is the intensified anti-drug campaign of the administration of President ... "Dela Rosa: We're winning the war on drugs". Rappler. "How Duterte's drug war can fail , War on drugs". The Philippine Star. ...
Committee on Monopoly (1975). Competitive Problems in the Drug Industry. Vol. 28. U.S. Government Printing Office. p. 13586. ... Obetrol' was the trade name when the drug was sold to wholesalers, while 'Oby-Rex' was the trade name used when the same drug ... the drug's name was changed from Obetrol to Adderall, and the drug was marketed for use in the treatment of Attention Deficit ... Drugs missing an ATC code, Drugboxes which contain changes to verified fields, Drugs that are a combination of chemicals, All ...
"Patent Bill Splits the Drug Industry". The New York Times. August 15, 1982. p. NJ4. "Helms: From Reagan Ally to Foe in One ... After the Drug Enforcement Administration encountered opposition from Oliver North in investigating Noriega's role in drug ... Helms supported the tobacco industry, which contributed more than 6% of the state's GSP until the 1990s (the highest in the ... He co-sponsored the bi-partisan move in 1982 to extend drug patent duration. Helms continued to pose obstacles to Reagan's ...
Hall, M. Floyd (May 7, 1995). "Caregiver Drug Buy Raises Industry Issues". The Morning Call. ProQuest 392690616. Graham, ... In 1995, the company attracted media attention when one of its home care employees was arrested while buying illegal drugs, and ...
Hall, M. Floyd (7 May 1995). "Caregiver Drug Buy Raises Industry Issues". The Morning Call. ProQuest 392690616. George, John ( ... In 1995 the company drew negative attention when one of its home care employees was arrested while buying illegal drugs, and ... Griswold was among the corporations that pushed for better government oversight of the home care industry. Griswold hired Ray ...
Children and Drug Industry's Role". The New York Times. Marilyn Elias (May 2, 2006). "New antipsychotic drugs carry risks for ... "Revealed: how drug firms 'hoodwink' medical journals , Society , The Observer". The Observer. "Prescription Drug Expenditures ... Drug companies routinely fund much of the research conducted by psychiatrists, advertise medication in psychiatric journals and ... The number of psychiatric drug prescriptions have been increasing at an extremely high rate since the 1950s and show no sign of ...
"FDA commissioner decries drug industry oligopoly". Supply Chain Dive. Vaillancourt, R (May 2012). "Drug shortages: what can ... Lazonick, William; Tulum, Öner (26 February 2019). "How High Drug Prices Inflate C.E.O.s' Pay". The New York Times. Tulum, Öner ... Drug companies on CEPI's scientific advisory panel, including Johnson & Johnson, Pfizer, and Japan's Takeda, pushed back. CEPI ... The financialization focus of the pharmaceutical industry, especially in the US, has been cited as an obstacle to innovation. ...
"China Orders Investigation into Drug Industry." BBC News. February 9, 2007. BBC News Archived 2007-02-12 at the Wayback Machine ... The drug quality inspectors at the factory that produced the Armillarisni A drugs failed to notice that the chemical diglycol ... "Death toll over fake drug rises to 9". 2006-05-22. Archived from the original on 2011-06-09. "Death toll in fake drug case ... The State Food and Drug Administration reported that their officials had resolved 14 cases involving fake drugs and 17 cases ...
The Drug Industry Documents Archive (DIDA) is a digital archive of pharmaceutical industry documents created and maintained by ... Wyeth paid medical ghostwriters to author journal articles about the drug. "About the Project". Drug Industry Document Archive ... The UCSF_Library created this digital archive in an attempt to facilitate further research into the drug industrys practice of ... DIDA is a part of the larger UCSF Industry Documents Library which includes the Truth Tobacco Industry Documents. The archive ...
Health Canadas independent drug review process is recognized around the world for its high standards and rigor. Our decisions ... On this date, Pfizer-BioNTech Comirnaty®transitioned to an authorization under the Food and Drug Regulations. ... Interim Order respecting the importation, sale and advertising of drugs for use in relation to COVID-19 ... sale and advertising of drugs for use in relation to COVID-19. The interim order expired on September 16, 2021. ...
Its not terribly surprising to learn that the animal drug industry operates like the human pharmaceutical industry does, using ... Its not terribly surprising to learn that the animal drug industry operates like the human pharmaceutical industry does, using ... Its not terribly surprising to learn that the animal drug industry operates like the human pharmaceutical industry does, using ... Its not terribly surprising to learn that the animal drug industry operates like the human pharmaceutical industry does, using ...
Accredited Drug Testing is pleased to announce that it has completed all training, regulatory requirements, facility ... Accredited Drug Testing Receives Prestigious Industry Accreditation. Accredited Drug Testing is pleased to announce that it has ... is the largest trade association representing the Nations drug testing industry, including laboratories, drug testing providers ... Accredited Drug Testing is one of the Nations leading providers of drug, alcohol and DNA testing services for employers and ...
The pills may indeed be miracle drugs - but they dont let the food, beverage and restaurant industries off the hook. ... The pills may indeed be miracle drugs - but they dont let the food, beverage and restaurant industries off the hook for making ... The new drugs can quickly attack the crisis in todays population with the highest rates of obesity - and if they prove to be ... Pills and drugs are very appealing to the consumer segment with the highest rates of obesity. These "Magic Bullets," as they ...
Provide the Agencys current thinking for the development of human drug products, including those that are biological products ... Drug Products, Including Biological Products, that Contain Nanomaterials - Guidance for Industry * Search for FDA Guidance ... Drug Products, Including Biological Products, that Contain Nanomaterials - Guidance for Industry April 2022 Download the Final ... Nanotechnology can be used in a broad array of FDA-regulated products, such as human drug products, including those that are ...
New code requires doctors to disclose all links with drug industry BMJ 2011; 342 :d2188 doi:10.1136/bmj.d2188 ... New code requires doctors to disclose all links with drug industry. BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d2188 ( ... Consultation starts on how to reveal payments from industry to doctors. Published: 29 January 2013; BMJ 346 doi:10.1136/bmj. ...
... can amplify and extend the beneficial effects of anti-diabetic drug Metformin, says a new peer review study. ... Industry review: Resveratrol enhances the effects of diabetic drug. By Nicola Cottam 13-May-2014. - Last updated on 14-May-2014 ... It is now one of only two anti-diabetic drugs on the World Health Organisations (WHO) list of Essential Medicines. ... can amplify and extend the beneficial effects of anti-diabetic drug Metformin, says a new peer review study. ...
... and eliminate subsidized prescription drug prices enjoyed by Canadians, CanWest News Service reports. ... Americas big drug companies are intensifying their lobbying efforts to change the Canadian health-care system ... U.S. Drug Industry Steps Up Lobbying in Canada. Submitted by Laura Miller on June 8, 2003 - 11:00pm. ... "A prescription drug industry spokesman in Washington confirmed to CanWest News Service that information contained in ...
Identifying Trading Partners Under the Drug Supply Chain Security Act Guidance for Industry August 2017 Download the Draft ... Identifying Trading Partners Under the Drug Supply Chain Security Act Guidance for Industry ... Food and Drug Administration. 5630 Fishers Lane, Rm 1061. Rockville, MD 20852 ...
Two Leaders in Pain Treatment Have Long Ties to Drug Industry. American Pain Foundation board members Scott Fishman and Perry ... Fine said his relationships with drug companies add to his knowledge about their products. "Does it bias me and cause me to be ... In an email to ProPublica, Fishman said he had stopped taking money from drug companies in recent years to avoid the perception ... In an interview, Fine said he tries to be fully transparent about his industry ties. After reviewing his tax records, Fine said ...
Source: US Food and Drug Administration, August 2019. [+]Enlarge Chinese plants make up 13% of all US-registered drug chemical ... Novel coronavirus puts drug chemical industry on alert Firms signal preparedness, but warn that prolonged plant closures and ... Chinese plants make up 13% of all US-registered drug chemical facilities.. ... Major drug companies have issued statements in recent days assuring the public that their inventories are adequate in the face ...
More trouble: Drug industry consolidation. Drug companies keep merging. Why thats bad for consumers and innovation.. Share on ... Works for the industry, but not so well for the people.. Were just trying to introduce single payer Medicare for All. How much ... Drug companies were drawn to merging because of the lure of increased market power, improved synergies, larger economies of ... Maybe we should be taking over the industry so that we can gear it up to better serve us, the people. International comparisons ...
By no coincidence, TMAP tends ot promote drug, drug, drug, drug, drug, drug, drug… starting with some of the most expensive ... fraud and cover-up by the psychiatric drug industry. Doctors can launder drug money PharmaTimes reports that an analysis ... Psychiatric Drug Industry Investigations of the undue influence by huge and profitable corporations that manufacture psychiaric ... Alert protests NASW link to psychiatric drug industry Nineteen social work academics have signed an open letter protesting the ...
Bulk Drug Manufacturers Association (BDMA), in a discussion on industry expectations from regulators at the iPHEX and Global ... Mutual recognition can save time and cut production costs to an extent, says R.K Agarwal, head of the bulk drug makers ... "The need of the industry in the regulation space is mutual recognition, which saves time and brings down the cost of production ... Stating that Europe was following mutual recognition of regulation to an extent, he said the pharma industry would be ...
What roles could computer scientists play in drug discovery - Free Course ... Intro to Drug Discovery for Computer Scientists. What roles could computer scientists play in drug discovery ... who want to explore and seek opportunities in healthcare industry R&D, specifically drug discovery. ... drug design resource grand challenge D3R and modeling of protein-drug interactions SAMPL. Among them, computational models and ...
PRNewswire-PRWeb/ -- Today Drug Channels Institute (DCI) released its exclusive analysis of U.S. prescription drug distribution ... New Drug Channels Institute Study: U.S. Drug Distribution Industry Gaining from Anti-Obesity Drugs and Provider-Administered ... About Drug Channels Institute. Drug Channels Institute is a leading source of industry research about pharmaceutical economics ... 10, 2023 /PRNewswire-PRWeb/ -- Today Drug Channels Institute (DCI) released its exclusive analysis of U.S. prescription drug ...
The president-elect pledged to crack down on high drug prices during his first press conference of 2017. ... "We have to get our drug industry coming back," Trump told reporters. "Our drug industry has been disastrous. Theyre leaving ... Donald Trump Just Called The Drug Industry "Disastrous". The president-elect pledged to crack down on high drug prices during ... "And theres very little bidding on drugs. Were the largest buyer of drugs in the world, and yet we dont bid properly. And ...
We have long been reporting about the mounting evidence that points to drug companies routinely hiding their influence over ... We have long been reporting about the mounting evidence that points to drug companies routinely hiding their influence over ... Ghostwriting Common Throughout Drug Industry. Posted: October 6, 2008. We have long been reporting about the mounting evidence ... The conference, Sealey noted, was only a week away and she had never heard to the drug that had been tested. According to ...
... headlined by the impact the Medicare Prescription Drug Benefit legislation will have in the USA. - News - PharmaTimes ... PricewaterhouseCoopers has issued a report on the top 10 business issues for the pharmaceutical and other healthcare industries ... In 2006, says PwC, the pharmaceutical industry will be focused on boosting R&D productivity and cutting costs and many drug ... Medicare is top issue facing US drug industry in 2006. 11th January 2006. ...
Industrys Current Valuation. Since most companies in the biotech sector do not have approved drugs, valuing these companies ... Zacks Industry Rank Indicates Decent Prospects. The groups Zacks Industry Rank is basically the average of the Zacks Rank of ... Industry Versus S&P 500 & Sector The Zacks Biomedical and Genetics industry is a 481-stock group within the broader Zacks ... Innovation, Execution Hold the Key: As only a few companies in this industry have approved drugs in their portfolio, the focus ...
275 Pages Report] North American Drug Delivery Technologies Market report categorizes the global market by End User (Hospital, ... 7.9 Transmucosal Drug Delivery. 7.9.1 Oral Transmucosal Drug Delivery. 7.9.1.1 Buccal Drug Delivery. 7.9.1.2 Sublingual Drug ... 7.5 Ocular Drug Delivery. 7.5.1 Ocular Drug Delivery Formulations. 7.5.1.1 Liquid Drug Delivery. 7.5.1.1.1 Eye Drops. 7.5.1.1.2 ... 7.5.2 Ocular Drug Delivery Devices. 7.5.2.1 Ocular Inserts. 7.5.2.2 Contact Lenses Coated With Drugs. 7.6 Nasal Drug Delivery. ...
New Report Debunks Drug Industry Claims About the Cost of New Drug Research and Development ... "The drug industry is stealing from us twice," Clemente said. "First it claims that it needs huge profits to develop new drugs, ... New Report Debunks Drug Industry Claims About the Cost of New Drug Research and Development. ... "This R&D scare card is built on myths and falsehoods that are maintained by the drug industry to block Medicare drug coverage ...
This article will discuss the major industries and jobs that demand drug testing. ... Drug testing has become a standard practice in many industries over the years. ... Industries That Require Drug Testing. The following are some of the major industries that require drug testing:. 1. Government ... Drug testing laws. Many states have laws that require drug testing in certain industries, including transportation, healthcare ...
... August 9th, 2018 Wise ... The drug discovery outsourcing market appears to be highly fragmented. The industry research report provides a comprehensive ... This report studies the global Drug Discovery Outsourcing market size, industry status and forecast, competition landscape and ... This research report categorizes the global Drug Discovery Outsourcing market by companies, region, type and end-use industry. ...
... in September published proposed mandatory guidelines for federal workplace drug-testing ... "Everyone in the industry knows that hair testing will reveal a much greater history of drug use than a urine test will. The ... Proposed guidelines for hair drug testing stir debate in trucking industry. By Lyndon Finney - October 2, 2020. ... "Time and again, trucking has represented itself as a zero-tolerance industry when it comes to drugs and alcohol in the ...
Collection of Race and Ethnicity Data in Clinical Trials: Guidance for Industry and Food and Drug Administration Staff ...
There has been a number of significant appointments in the drug discovery sector over the last month. So who are the latest ... Posted in News , Tagged Appointment, Big pharma, Drug discovery, Life sciences, New appointment, Pharmaceutical industry ... Posted in News , Tagged Appointment, Big pharma, Drug discovery, Life sciences, New appointment, Pharmaceutical industry ... Partners use AI tools to advance novel drugs for geographic atrophy 24 April 2023 ...
A theory of "gateway drug" since debunked by science.. Now, heavily invested in the drug testing industry, DuPont has passed ... Drug testing in the workplace is part of the war on drugs and it exists solely because of Washington, the drug war, and ... No doubt about whose side Robert DuPont is on: “Stopping workplace drug testing for marijuana and other drugs of abuse would ... 38 Responses to Robert DuPont as shill for the drug testing industry * darkcycle. says: ...
  • Stating that Europe was following mutual recognition of regulation to an extent, he said the pharma industry would be benefitted by coordination between regulators. (thehindubusinessline.com)
  • At last, you will get a chance to learn from people working in the field of drug discovery to see what role computer scientists are playing working in the related industry, including big pharma Research & Development, biotech company or software company developing drug design tools. (udemy.com)
  • Given the dynamic and evolving nature of technology, the sector is perceived to be riskier than the more stable large-cap pharma or drug industry. (247wallst.com)
  • This is because leading pharma/biotech companies look to diversify their revenue base in the face of dwindling sales of high-profile drugs. (247wallst.com)
  • Public Citizen challenges Big Pharma, device manufacturers and federal regulators to make drugs and medical devices safe, effective and accessible to all. (citizen.org)
  • Pharma companies need to reduce the expenses of new drug launches to save money in an environment prohibiting expensive new drugs. (worldofdtcmarketing.com)
  • Dr. Smith - a 25-year veteran of British pharma giant GlaxoSmithKline (GSK) and drug development consultant at Princeton University - said while some partnerships are built on relatively straightforward licensing deals, others require more complex collaborations from conception of a topic through to choosing a clinical candidate for a product. (springboardatlantic.ca)
  • ILI's Grant said the conference also presented an opportunity for Dal to connect more closely with national industry reps for the big pharma companies, seven of whom were represented at the event. (springboardatlantic.ca)
  • After a decent performance in the first half of 2023, the outlook for the second half of 2023 for the biotech industry looks upbeat as the world cautiously wades through an uncertain macroeconomic environment. (247wallst.com)
  • This research report identifies the prioritization of core competencies to be one of the primary growth drivers for the global drug discovery outsourcing market till 2022. (medgadget.com)
  • The human toll of Ecuador's transformation into a major drug trafficking hub has been immense, reflected in the country's highest recorded annual number of violent deaths in 2022, at 4,600, double the previous year. (yahoo.com)
  • The Global Drug sales of Opdivo stood at USD 9,566.59 Million in 2022, while Keytruda was over $20 billion. (worldofdtcmarketing.com)
  • In 2022, approximately 110,000 Americans died from a drug overdose. (cdc.gov)
  • In January 2022, there were about 428,000 people working in the legal cannabis industry across the country. (cdc.gov)
  • Where the Transdermal Drug Delivery market is heading? (visiongain.com)
  • According to Viranchi Shah, President, Indian Drug Manufacturers' Association (IDMA), it would be prudent for regulators of other countries to accept approvals issued by the Indian regulator. (thehindubusinessline.com)
  • Moreover, the outlook provided by the companies indicates bright prospects now on the back of new drug approvals and positive pipeline updates. (247wallst.com)
  • With the pandemic creating havoc and the focus mostly on coronavirus treatments in the last couple of years, the industry saw a slowdown in new drug approvals for other diseases. (247wallst.com)
  • Nevertheless, with increasing R&D spend and most companies looking to diversify, new drug approvals are likely to see an acceleration going forward. (247wallst.com)
  • The North American drug delivery technologies market is projected to reach USD 758.7 Billion by 2021 from USD 520.0 Billion in 2016, at a CAGR of 6.5% during the forecast period. (marketsandmarkets.com)
  • The U.S. market is expected to dominate the North American drug delivery technologies market in 2016 and is projected to grow at the highest CAGR during the forecast period. (marketsandmarkets.com)
  • A new market study, titled "Global Drug Discovery Outsourcing Market Size, Status and Forecast 2025", has been featured on WiseGuyReports. (medgadget.com)
  • This report studies the global Drug Discovery Outsourcing market size, industry status and forecast, competition landscape and growth opportunity. (medgadget.com)
  • To study and forecast the market size of Drug Discovery Outsourcing in global market. (medgadget.com)
  • The global antifungal drugs market size was valued at USD 10.24 billion in 2019 and is projected to reach USD 13.17 billion by 2027, exhibiting a CAGR of 3.3% during the forecast period. (fortunebusinessinsights.com)
  • The report evaluates the size of the global Smart Drugs market for the base year 2020 and the forecast between 2020 and 2025. (ipsnews.net)
  • The report reviews the competitive landscape scenario seen among top players, their company profile, revenue, sales, business tactics, and forecast industry situations. (ipsnews.net)
  • This high-end research comprehension titled Global Inflammatory Bowel Disease Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 skillfully presents a comprehensive study of the market, measuring the past and current market values, and predicting future market orientation between the forecast periods from 2020 to 2025. (pharmiweb.com)
  • The major sections that are included within the report are global Inflammatory Bowel Disease Drugs market size and forecast, drivers, limitations, opportunities, and challenges. (pharmiweb.com)
  • Other off-patent drugs with rising prices and no generic competition have also drawn scrutiny, including Turing Pharmaceuticals' Daraprim, for toxoplasmosis, and Valeant's cardiovascular drugs Isuprel and Nitropress. (wfdd.org)
  • Dr Reinstein did eventually switch patients to a less expensive generic version of the drug, but only after IVAX Pharmaceuticals LLC and Teva Pharmaceuticals USA Inc agreed to pay him consulting fees and finance a clozapine research study carried out by an affiliated entity with a paid assistant specified by the psychiatrist. (medscape.com)
  • The UCSF_Library created this digital archive in an attempt to facilitate further research into the drug industry's practice of establishing close links with the medical community which has been shown to influence scientific research, drug approval, prescription practices, and ultimately, consumer health. (wikipedia.org)
  • In a statement provided to BuzzFeed News, Stephen Ubl, president and CEO of the pharmaceutical industry's lobbying group PhRMA, said that the industry is committed to working with the President-elect. (buzzfeednews.com)
  • The Biden administration's first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry's price negotiators is backfiring, pharmacists say. (thelundreport.org)
  • The end result of now three waves of pharmaceutical consolidation is decreased or diverted new drug innovation, fewer treatment options and higher prices. (pnhp.org)
  • The article describes how we can expect decreased or diverted drug innovation, fewer treatment options, and above all, higher prices. (pnhp.org)
  • As the industry is looking for new sources of discovery and innovation with limited resources, there is a growing preference to move towards externalization and willingness to embrace the concept of outsourcing. (medgadget.com)
  • In an era where science and technology have advanced at an unprecedented rate, one would expect that the pharmaceutical industry, at the forefront of medical innovation, would be held in high regard. (worldofdtcmarketing.com)
  • The intensive two-day educational event was the brainchild of Doris Grant and Andrea McCormick of Dal's Industry Liaison and Innovation (ILI) office, a team that helps facilitate the commercialization of research at the university. (springboardatlantic.ca)
  • DIDA contains: internal pharmaceutical company documents correspondence between drug companies and physicians, researchers and educational institutions regulatory and legal documents court filings depositions expert reports internal University documents Documents come from a variety of sources including: Lawsuits against Merck & Co. regarding the marketing and use of Vioxx The landmark whistleblower case involving Neurontin (gabapentin) and off-label marketing: United States of America ex rel. (wikipedia.org)
  • At some high-profile journals published by the Federation of Animal Science Societies, like the Journal of Animal Science and Journal of Dairy Science , for example, 'corporate agribusinesses and drug companies act as sponsors, directors, editors, and frequent authors. (commondreams.org)
  • America's big drug companies are intensifying their lobbying efforts to 'change the Canadian health-care system' and eliminate subsidized prescription drug prices enjoyed by Canadians," CanWest News Service reports. (prwatch.org)
  • The University requires doctors to disclose all ties to drug companies, even situations in which they are not compensated. (propublica.org)
  • Fine said his relationships with drug companies add to his knowledge about their products. (propublica.org)
  • In an email to ProPublica, Fishman said he had stopped taking money from drug companies in recent years to avoid the perception of a conflict of interest. (propublica.org)
  • Major drug companies have issued statements in recent days assuring the public that their inventories are adequate in the face of supply chain threats stemming from China's coronavirus outbreak. (acs.org)
  • Drug companies keep merging. (pnhp.org)
  • As a result, now only a handful of manufacturers are responsible for sourcing the vast majority of prescription drugs: Just four companies, for example, produced more than 50 percent of all generic drugs in 2017. (pnhp.org)
  • Drug companies were drawn to merging because of the lure of increased market power, improved synergies, larger economies of scale and more diverse product portfolios. (pnhp.org)
  • Merged drug companies also spent proportionally less on research than their non-merged competitors. (pnhp.org)
  • As with the earlier waves, giant drug companies have merged. (pnhp.org)
  • And on the campaign trail, Trump said that he could save Medicare "$300 billion" a year by letting it negotiate drug prices directly with pharmaceutical companies. (buzzfeednews.com)
  • For the pharmaceutical industry, it suggests, companies may need to examine their product portfolios as consumers become increasingly price-sensitive and comparison-shop for generic drugs and other alternatives. (pharmatimes.com)
  • In 2006, says PwC, the pharmaceutical industry will be focused on boosting R&D productivity and cutting costs and many drug companies will boost their efforts to form strategic alliances and joint ventures with biotech firms as a source for new products. (pharmatimes.com)
  • The Zacks Biomedical and Genetics industry includes biopharmaceutical and biotechnology companies that develop high-profile drugs using path-breaking technology. (247wallst.com)
  • As only a few companies in this industry have approved drugs in their portfolio, the focus is primarily on the performance of high-profile drugs and pipeline development. (247wallst.com)
  • Most companies spend millions and billions to create a drug with path-breaking technology, which leads to significant research and development expenditure. (247wallst.com)
  • Cost synergies in research and development are added benefits, as quite a few smaller biotech companies are using innovative technologies to develop drugs and treatments. (247wallst.com)
  • The report reveals how major U.S. drug companies and their Washington lobby group, the Pharmaceutical Research and Manufacturers of America (PhRMA), have carried out a misleading campaign to scare policymakers and the public. (citizen.org)
  • Companies and organizations conduct drug tests for various reasons, including complying with state and federal regulations, maintaining a safe work environment, and improving productivity. (blaugh.com)
  • This research report categorizes the global Drug Discovery Outsourcing market by companies, region, type and end-use industry. (medgadget.com)
  • Using 151,662 paired pre-employment urine and hair drug test results from 15 different trucking companies, the results of the study indicated that 949 (0.6%) applicants failed the urine test, while 12,824 (8.5%) failed or refused the hair test. (thetrucker.com)
  • CAMBRIDGE, MA (August 24, 2016) - The number of drug candidates in clinical trials from Massachusetts-headquartered companies increased by 14% from 2014, and the total number of drug candidates increased to 1,645, a 10% increase, according to an annual industry report published by MassBio. (massbio.org)
  • Medium-to-large size pharmaceutical companies can be loosely defined as organizations involved in drug discovery and early- to late-stage clinical development and have significant clinical, manufacturing, marketing, and commercial activities with a sizable workforce. (aspetjournals.org)
  • CMS' plan to help create value-based arrangements for prescription drugs in Medicaid programs was rejected or criticized by a range of stakeholders, including hospitals, insurers, drug companies, medical schools and Medicaid directors. (modernhealthcare.com)
  • But pharmaceutical companies have avoided value-based arrangements with commercial payers because they're concerned about the best price guarantee in Medicaid's drug rebate program. (modernhealthcare.com)
  • Pharmacy benefit managers (PBMs) and pharmaceutical companies have been locked in a battle over the cost of prescription drugs for years. (worldofdtcmarketing.com)
  • PBMs, third-party companies that administer prescription drug benefits for health insurers, argue that they are working to reduce drug costs for patients. (worldofdtcmarketing.com)
  • Most industry experts don't believe that the new administration will have the same appetite for trying to enforce stringent clinical standards in cases where companies have offered science and qualified experts in support of their claims. (fdli.org)
  • The conference included lectures, hands-on simulations and one-on-one consultations with industry veterans on everything from the language and skills needed to engage the interest of industry and large biotech companies to understanding the processes that can increase the likelihood of establishing funding partnerships. (springboardatlantic.ca)
  • With the cost of drug development in excess of $800 million, pharmaceutical manufacturers are under pressure from stakeholders to produce even as their margins erode. (pharmatimes.com)
  • Trucking-industry stakeholders have long contended that hair testing is far more reliable in identifying substance abusers than urine testing. (thetrucker.com)
  • PwC expects a significant increase in voluntary or even mandatory health promotion and wellness initiatives, and there will be a growing market for drugs, treatments and services oriented toward wellness and prevention. (pharmatimes.com)
  • Given the continuous need for innovative medical treatments, irrespective of the state of the economy, the biotech industry can be a haven despite the inherent volatility and uncertain macroeconomic environment. (247wallst.com)
  • The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to. (visiongain.com)
  • Collaborative working between the NHS and industry could reduce variations in uptake of innovative treatments across the UK, a joint report from NHS Confederation and ABPI argues. (ddw-online.com)
  • Those pay-for-performance contracts would connect drug payments to clinical outcomes, allowing drugmakers to get paid based on how much their therapies improve care instead of the number of drugs or treatments sold. (modernhealthcare.com)
  • With few targeted treatments, and average drug costs exceeding USD 100,000 a year, rare diseases are a burgeoning area of study with enormous potential for drug development. (wns.com)
  • The 2016 MassBio Industry Snapshot shows that in the last 10 years, Massachusetts biopharma manufacturing employment has grown by 34% to 10,616 jobs statewide. (massbio.org)
  • Prevalence of self-reported prescription opioid use and illicit drug use among U.S. adults: NHANES 2005-2016. (cdc.gov)
  • Objective: To estimate the self-reported prevalence of prescription opioid use and illicit drug use in the U.S. Methods: Self-reported prescription opioid use and illicit drug use (mostly non-opioid) were obtained for adults and adult workers (NHANES 2005-2016). (cdc.gov)
  • Corporate agribusinesses depend on favorable science--often in the form of published research in academic journals--to gain legitimacy, regulatory approval, and market acceptance of products such as new animal drugs. (commondreams.org)
  • It's not terribly surprising to learn that the animal drug industry operates like the human pharmaceutical industry does, using its immense resources to capture and control the scientific research about its products. (commondreams.org)
  • In fact, most of the available research examined commercial dimensions of Zilmax, such as the drug's impact on beef qualify, and more than three-quarters of the studies were authored and/or funded by industry groups, almost all of which were published in scientific journals sponsored and edited by industry groups. (commondreams.org)
  • Calling for increased transparency from academic journals, as well as for the federal Food and Drug Administration to dramatically revamp its animal drug approval process to be based primarily on independent science, Hauter added: 'It's time that we put an end to the damaging and pervasive industry bias that exists throughout agricultural research. (commondreams.org)
  • The Pharmaceutical Research and Manufacturers of America (PhRMA) is the leading drug industry trade group behind the increased lobbying and PR campaign. (prwatch.org)
  • Faced with stagnating research productivity, large drugmakers now rely on outsourcing their new drug research to start-ups and other small pharmaceutical firms. (pnhp.org)
  • Increasingly, these smaller players specialize in high-risk research and early drug development, with larger firms then gobbling them up and navigating the FDA's regulatory process. (pnhp.org)
  • This bill, which went into effect on January 1, will inflate Medicare's share of US prescription drug spending from just 2% in 2005 to a hefty 28% this year, according to PwC's Health research Institute, creating a powerful single purchaser of drugs that will be able to negotiate strongly on price. (pharmatimes.com)
  • Growth in this market is primarily driven by the rising prevalence of chronic diseases, growth in the biologics market, funding initiatives for drug delivery research, and technological advancements. (marketsandmarkets.com)
  • Factors such as rising prevalence of chronic diseases, growth in the biologics market, funding initiatives for drug delivery research, and technological advancements are driving the growth of the North American drug delivery technologies market. (marketsandmarkets.com)
  • WASHINGTON, D.C. The pharmaceutical industry spends about one-fifth of what it says it spends on the research and development (R&D) of new drugs, destroying the chief argument it uses against making prescription drugs affordable to middle and low-income seniors, a Public Citizen investigation has found. (citizen.org)
  • PhRMAs central claim is that the industry needs extraordinary profits to fund "risky" and innovative research and development to discover new drugs. (citizen.org)
  • The industry research report provides a comprehensive analysis of the market's competitive landscape and the growth prospects for vendors in the drug development & outsourcing market. (medgadget.com)
  • Meanwhile, scientific research on the efficacy of drug testing in the workplace remains mysteriously limited, or absent. (drugwarrant.com)
  • Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. (kaloramainformation.com)
  • Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers. (kaloramainformation.com)
  • Oncology drugs make up 36% of that pipeline with systemic anti-infectives, central nervous system, and musculoskeletal therapeutic areas as other strong areas of research. (massbio.org)
  • Massachusetts biomanufacturing employment grew by 6.3% year over year, outpacing other industry subsectors in 2015, including research and development. (massbio.org)
  • The ability of scientists with a background in biotransformation and organic chemistry to creatively solve complex drug metabolism problems encountered during research and development efforts on both small and large molecular modalities is exemplified in five relevant case studies. (aspetjournals.org)
  • Graduate research activities involving mechanistic studies on xenobiotic toxicity invariably expose students to the field of drug metabolism, particularly in cases where xenobiotics are enzymatically bioactivated to electrophilic reactive metabolites that can covalently adduct to proteins and DNA and cause toxicity. (aspetjournals.org)
  • The market research depends upon these common segmentations such as application, end-use industry, service and solution, component, and majorly on the regional significance. (pharmiweb.com)
  • About 40 academics - including researchers, post-docs and grad students from Dal and Cape Breton University - participated in the event along with members from Innovative Medicines Canada, an industry association for the national pharmaceutical industry that partnered with the ILI and other groups on the event including Dalhousie Medical Research Foundation, Springboard Atlantic, BioNova and the Dalhousie Faculty of Medicine. (springboardatlantic.ca)
  • They're learning how to create data in their labs and identify resources for creating that data to interest partners in the development of medicines - how to translate their basic bench-top research into biotech industry products," said Dr. Chari Smith, one of the three consultants brought in for the event. (springboardatlantic.ca)
  • Specifically, this guidance addresses the Food and Drug Administration's (FDA's) current thinking regarding the overall development program and clinical trial designs for systemic drugs administered to the kidney transplant recipient to support an indication of prevention of DGF. (fda.gov)
  • Many patients were in the dark about EpiPen price increases until insurers started shifting more of the cost onto consumers a few years ago, and getting approval for a generic that's both a drug and a device is more complicated than getting approval for a drug alone, he said. (wfdd.org)
  • But providers, insurers, state Medicaid directors and prescription drug manufacturers say they need more time to understand CMS' plan and it's far-reaching effects, warning the agency that it's challenging to know the impacts of the proposed rule because CMS didn't study them. (modernhealthcare.com)
  • PBMs sit at the center of the U.S. supply chain for drugs, where they say they negotiate lower prices for insurers - including Medicare - and for employers and their workers. (thelundreport.org)
  • The president-elect pledged to crack down on high drug prices during his first press conference of 2017. (buzzfeednews.com)
  • Drug overdoses have accelerated over the past two decades, and in 2017, the United States Department of Health and Human Services deemed the opioid crisis a public health emergency. (cdc.gov)
  • MarketandResearch.biz has presented Global Smart Drugs Market Growth 2020-2025 aims to make you knowledgeable about the market and competitive landscape which supports you with enhanced decision making. (ipsnews.net)
  • It discusses the present situation and the development possibilities of the industry for 2020-2025. (ipsnews.net)
  • Global Neuraminidase Inhibitors Drug Market Growth (Status and Outlook) 2020-2025 showcases the market's comprehensive study and reliable market statistics. (pharmiweb.com)
  • The foundation received 88 percent of its $5 million income last year from drug and medical-device makers. (propublica.org)
  • As a result of the growth in combination products and the continued blurring of the lines between drugs, diagnostics and devices, MassBio has also started to track the performance of the medical device segment of the life sciences industry. (massbio.org)
  • The US Food and Drug Administration (FDA) began regulating SGBIs in 1976 with the passage of the Medical Device Amendments. (medscape.com)
  • Generic products are non-patented chemical and therapeutic equivalents of brand name drugs. (kaloramainformation.com)
  • Dr. Simms, who is also a team leader with a Dal spinout company tentatively called NovaSight that is developing a therapeutic drug to treat a rare form of childhood blindness, said the conference further hammered home for him just how important it is to have intellectual property on discoveries. (springboardatlantic.ca)
  • In the case of Zilmax, a growth-promoter that was removed from the marketplace in 2013 due to animal safety concerns, the Food & Water Watch report found that there had been virtually no independent, peer-reviewed studies into the safety of the drug for cattle. (commondreams.org)
  • But a new report from Food & Water Watch charges the industry with playing an enormous and hard-to-track role in the production of such studies. (commondreams.org)
  • I write about social and ethical leadership in the food industry. (forbes.com)
  • The pills may indeed be miracle drugs - but they don't let the food, beverage and restaurant industries off the hook for making their indulgent products more healthful, as PepsiCo is doing. (forbes.com)
  • US Food and Drug Administration, August 2019. (acs.org)
  • During the application of the IO, Canadian importers may bring designated drugs into the country and sell them without meeting all the requirements of the Food and Drug Regulations . (canada.ca)
  • Consumers and lawmakers pushing for cheaper alternatives to the EpiPen, an antidote for life-threatening allergic reactions, and other high-priced drugs are seeking answers about a stubborn backlog of generic drug applications at the Food and Drug Administration. (wfdd.org)
  • Sidley was the first international law firm to establish a stand-alone, comprehensive food and drug regulatory practice in China. (sidley.com)
  • Sidley is also the first law firm to have been honored with a Memorandum of Understanding (MOU) issued by the Shanghai Institute for Food and Drug Safety in January 2008, under which Sidley provides input in the formulation of new drug and device laws and sponsors annual drug safety seminars for international audiences. (sidley.com)
  • The Federal Trade Commission (FTC) and Food and Drug Administration (FDA) are the two primary federal agencies that regulate the dietary supplement industry. (fdli.org)
  • In this context, Saudi Arabia's Food and Drug Authority has adopted specific policies to regulate governmental official communications with the tobacco industry, including tobacco manufacturers, wholesale distributors and importers of tobacco products. (who.int)
  • Consultancy firm PricewaterhouseCoopers has issued a report on the top 10 business issues for the pharmaceutical and other healthcare industries in 2006, headlined by the impact the Medicare Prescription Drug Benefit legislation will have in the USA. (pharmatimes.com)
  • This R&D scare card is built on myths and falsehoods that are maintained by the drug industry to block Medicare drug coverage and measures that would rein in skyrocketing drug costs," said Frank Clemente, director of Public Citizen's Congress Watch. (citizen.org)
  • Both contain semaglutide, a drug approved by the FDA in 2021 for people who have obesity or who are overweight with other medical risks. (forbes.com)
  • Pills and drugs are very appealing to the consumer segment with the highest rates of obesity. (forbes.com)
  • The global obesity epidemic has prompted significant interest and investment in developing and marketing obesity drugs. (worldofdtcmarketing.com)
  • However, the question arises: Is the market for obesity drugs overvalued? (worldofdtcmarketing.com)
  • Several factors suggest caution is warranted when evaluating the prospects of obesity drugs. (worldofdtcmarketing.com)
  • Since a drug that induces weight loss improves outcomes, the next logical idea would be that obesity is not healthy. (medscape.com)
  • This document provides guidance on the development of human drug products, including those that are biological products, in which a nanomaterial is present in the finished dosage form. (fda.gov)
  • While taking courses in OMSCS as part of the professional development plan, she is hoping to help advocate the advances in computational science and embrace the opportunities in the future of drug discovery. (udemy.com)
  • The purpose of this guidance is to assist sponsors in the clinical development of drugs for the prevention of delayed graft function (DGF) in kidney transplantation. (fda.gov)
  • Dr Kabbinavar will oversee the clinical development program for the company's investigational drug onvansertib and will report directly to Chief Executive Officer, Mark Erlander, PhD. (ddw-online.com)
  • Furthermore, players are also focusing on the development of drugs such as Amphotericin B which is a topical nanoemulsion formulation Antifungal drug for the treatment of candidiasis & aspergillosis, thereby triggering the market growth. (fortunebusinessinsights.com)
  • The Massachusetts drug development pipeline includes 13 candidates that are pending FDA approval. (massbio.org)
  • Massachusetts accounts for 13% of the U.S.-based drug development pipeline. (massbio.org)
  • SIGNIFICANCE STATEMENT Biotransformation and mechanistic drug metabolism scientists are critical to advancing chemical entities through discovery and development, yet the number of scientists academically trained for this role is on the decline. (aspetjournals.org)
  • A common entry point for these graduates in a pharmaceutical company is in a laboratory-based role within specialized biotransformation groups supporting metabolite identification needs for drug discovery and development. (aspetjournals.org)
  • National NHS leaders should improve engagement between the life sciences industry and their national and local colleagues, to make easier for the NHS to know about development in medicines, and how these can be implemented in care pathways. (ddw-online.com)
  • A drug development boot camp hosted by Dalhousie this week offered both researchers and pharmaceutical industry reps a chance to come together under one roof to sharpen their skills and improve their chances of building successful partnerships across academic and industry boundaries. (springboardatlantic.ca)
  • MACPAC said it's "concerned that while these changes could incentivize the use of (value-based payment) in the commercial market, they would also negatively affect the Medicaid program and do little to address concerns about the impact of high-cost specialty drugs on Medicaid program spending. (modernhealthcare.com)
  • Thus, the increase in prevalence of cryptococcosis is fueling the demand for these drugs in the market. (fortunebusinessinsights.com)
  • The increasing prevalence of inflammatory diseases namely ulcerative colitis, inflammatory bowel, psoriasis, and rheumatoid arthritis, and others are the major anti-inflammatory drugs market growth driver. (medgadget.com)
  • Prevalence of illicit drug use was 9.5% (8.8-10.1) (adults) and 10.2% (9.4-11.1) (workers). (cdc.gov)
  • The prevalence of illicit drug use among certain occupational groups suggests the need to ensure access to therapy. (cdc.gov)
  • This encourages drug makers to outsource drug discovery and use it as a popular tool to restructure internal resource deployment. (medgadget.com)
  • Thus, while federal law requires supplement makers to ensure that their products comply with all FDA regulations before they market them, the fact that they aren't approved by FDA before market is something that foes of the supplement industry have been critical of since DSHEA was enacted 23 years ago, and just one reason why industry self-regulation is so important. (fdli.org)
  • The report also offers interesting insights into the market, current trends, and significant industry developments. (medgadget.com)
  • In a statement, Express Scripts said that "our reimbursement rates to pharmacies for brand drugs vary based on a number of factors. (thelundreport.org)
  • Strategic partners can provide invaluable support in navigating the complex regulatory landscape, developing pricing and reimbursement strategies, and creating market access strategies for orphan drugs. (wns.com)
  • PhRMA is also spending $450,000 to target the booming Canadian Internet pharmacy industry, which provides Americans with prescription drugs at lower prices than in the United States. (prwatch.org)
  • In April of 2021, the U.S. surpassed 100,000 drug overdose deaths for the preceding 12-month period, marking a nearly 29% increase from the previous 12-months. (cdc.gov)
  • A new rule, which governs Medicare's drug program, is set to take effect Jan. 1 and requires PBMs to take most of their "performance fees" at the time prescriptions are filled. (thelundreport.org)
  • C&EN has made this story and all of its coverage of the coronavirus epidemic freely available during the outbreak to keep the public informed. (acs.org)
  • With over 30 years' experience in informatics and life sciences, Steve brings an extensive sales and marketing record that will be instrumental to the continued global commercialisation and adoption of Optibrium's innovative computational and AI drug discovery technologies. (ddw-online.com)
  • As an integral part of our Global Life Sciences practice, we bring our knowledge of industry practices in the U.S. and EU to each project in China and help develop global Standard Operating Procedures (SOPs) and benchmark best practices. (sidley.com)
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information. (ddw-online.com)
  • The Trucking Alliance in 2019 conducted a study comparing pass/fail rates for urine and hair drug screens. (thetrucker.com)
  • Adverse events leading to stopping the drug occurred in 16.6% of those taking semaglutide (weekly dose of 2.4 mg) vs 8.2% on placebo. (medscape.com)
  • For patients with established vascular disease who are overweight or obese, semaglutide is a disease-modifying drug. (medscape.com)
  • The report encompasses the critical aspects of the global Inflammatory Bowel Disease Drugs market like market size estimations, company and market best practices, market dynamics, market segmentation, competitive landscaping, opportunity analysis, economic forecasting, guideline analysis. (pharmiweb.com)
  • As dispensing medication in an among adults attending pharmacies in Al- appropriate way is a cornerstone of rational exandria, to identify their knowledge and drug use, the dispenser should be regularly self-reported practices concerning the usage updated with information, tools and skills of the purchased drugs and to calculate the [ 3 ]. (who.int)
  • This course is developed for computer science, computer engineering college students and/or professionals in this field, who want to explore and seek opportunities in healthcare industry R&D, specifically drug discovery. (udemy.com)
  • In comments on the proposed rule, they argue that CMS is rushing its plan to help state Medicaid programs, health plans and drugmakers create value-based arrangements for prescription drugs and it could cause severe problems for states and the healthcare industry. (modernhealthcare.com)
  • However, risk of needlestick injuries and side effects related to drugs are expected to restrain the growth of this market in the coming years. (marketsandmarkets.com)
  • The North American drug delivery technologies market is segmented on the basis of route of administration, end user, and country. (marketsandmarkets.com)
  • This report covers the North American drug delivery technologies market by route of administration, end user, and country. (marketsandmarkets.com)
  • The drug discovery outsourcing market appears to be highly fragmented. (medgadget.com)
  • Where the Urothelial Cancer Drugs market is heading? (visiongain.com)
  • Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. (visiongain.com)
  • Thus, the availability of diverse antifungal drugs for the treatment of fungal infection and over-the-counter drugs for the treatment of dermal infection is positively influencing the antifungal drug market growth. (fortunebusinessinsights.com)
  • Increase in Usage of Nanotechnology in Formulation of Advanced Antifungal Drugs to Propel Market Growth. (fortunebusinessinsights.com)
  • Moreover, the introduction of nanostructured drug delivery systems for the treatment of oral and vaginal candidiasis is emerging as one of the critical factors bolstering growth of the market. (fortunebusinessinsights.com)
  • The report further discusses the segmentation of the market based on factors such as drug-class, application, route of administration, distribution channel, and geography, and lists the names of the leading segment with attributed factors. (medgadget.com)
  • Moreover, an exceptionally workable estimation of the present industry scenario has been given in the study, and the global Smart Drugs market size with regards to the revenue and volume have also been mentioned. (ipsnews.net)
  • The report offers participants' financial overview which includes an assessment of revenue outcomes, sales volume, gross margin, capital investment, and global Smart Drugs market growth rate. (ipsnews.net)
  • NOTE: This report takes into account the current and future impacts of COVID-19 on this industry and offers you an in-dept analysis of Smart Drugs market. (ipsnews.net)
  • The global market report covers particular aspects of the global Smart Drugs market including the product classification, product details, scope of uses and major geographical producing regions. (ipsnews.net)
  • Global Neuraminidase Inhibitors Drug Market 2020 Industry. (pharmiweb.com)
  • The report analysts have collected and segregated data for the global Neuraminidase Inhibitors Drug market. (pharmiweb.com)
  • The profiling of these giant industry players includes its market share, new product developments, strategic methods, sales, mergers and acquisitions, and much more. (pharmiweb.com)
  • The report sheds light on important aspects such as global Neuraminidase Inhibitors Drug market segmentation, regional analysis, and company profiles of market players involved in the business. (pharmiweb.com)
  • The market size section provides historical forecasts for global Neuraminidase Inhibitors Drug market growth and the future. (pharmiweb.com)
  • Global Inflammatory Bowel Disease Drugs Market 2020 Compe. (pharmiweb.com)
  • The main motto of the report is to outline, segment, and project the market concerning global Inflammatory Bowel Disease Drugs market dynamics and other factors. (pharmiweb.com)
  • The Inflammatory Bowel Disease Drugs market is classified into different sections to provide a clear understanding of the various aspects of the market. (pharmiweb.com)
  • Sales accumulated by each regional global Inflammatory Bowel Disease Drugs market and anticipated market share over the projected timeframe have been given. (pharmiweb.com)
  • 5 ]. It also allows pharmaceutical compa- tional allocation technique, where 30 en- nies to expand their market [ 6 ]. (who.int)
  • The transportation industry, including truck drivers and pilots, requires drug testing. (blaugh.com)
  • A mechanism for the mutual recognition of regulatory approval for pharmaceutical products between countries will be beneficial for industry, according to experts. (thehindubusinessline.com)
  • AFIA spokesman, Richard Sellers said the association believes the approval of the new catfish animal drug, florfenicol (Aquaflor), as a veterinary feed directive drug will assist in the judicious use of this new drug - the first new aquaculture drug in more than 20 years. (aquafeed.com)
  • As of July 1, the FDA had 4,036 generic drug applications awaiting approval , and the median time it takes for the FDA to approve a generic is now 47 months, according to the Generic Pharmaceutical Association, a trade group. (wfdd.org)
  • The EMA along with the European Commission, which handles approval of marketing materials, are approving generics and brand-name drugs in about a year on average, according to the EMA. (wfdd.org)
  • When developing a new drug, the path to FDA approval is a long and complex journey, often taking years. (worldofdtcmarketing.com)
  • Hospitals/Medical Professionals must continue to report serious adverse drug reactions (C.01.020.1). (canada.ca)
  • Michael J. Reinstein, MD, was convicted of accepting payments from industry in the form of consulting fees, entertainment, and all-expense-paid vacations in exchange for prescribing and promoting first the brand-name version and then the generic version of the antipsychotic clozapine (multiple brands) to thousands of indigent elderly patients in Chicago-area nursing homes and hospitals. (medscape.com)
  • Industrial policy and the pharmaceutical industry : the proceedings of a symposium held on 22nd June 1994, London / edited by Adrian Towse. (who.int)
  • Moreover, it may take quite a few years for any newly-approved drug to contribute significantly to its company's top line. (247wallst.com)
  • A prescription drug industry spokesman in Washington confirmed to CanWest News Service that information contained in confidential industry documents is accurate and that $1 million US is being added to the already heavily funded drug lobby against the Canadian system. (prwatch.org)
  • The report, 'Transforming Lives, Improving Health Outcomes', highlights four initiatives where effective partnerships between the NHS, patient organisations and industry have helped to tackle unwarranted variation in the uptake of innovative medicines. (ddw-online.com)
  • Today's selection discusses consolidation within the pharmaceutical industry. (pnhp.org)
  • Following is a look at some of today's premier nostalgia drag race associations and what's keeping them on track. (performanceracing.com)
  • There are a lot of perspectives in drug design, so it's nice to get a good sense of all those perspectives because it's really easy to fall into your own little bubble of your experience and your knowledge," said Dr. Simms, who graduated with a PhD in Medicinal Chemistry from Dal last year. (springboardatlantic.ca)
  • The process is critical to ensure that employees are not under the influence of drugs or alcohol while on the job. (blaugh.com)
  • Pre employment drug screening involves testing an individual's biological specimen, such as urine, hair, or saliva, for the presence of drugs or alcohol. (blaugh.com)
  • These laws aim to ensure that employees are not under the influence of drugs or alcohol while on the job, thereby reducing the risk of accidents and injuries. (blaugh.com)
  • The tests help to ensure that healthcare workers are not under the influence of drugs or alcohol while on the job, which can impact patient care. (blaugh.com)
  • It ensures that these employees are not under the influence of drugs or alcohol while on the job, which can impact their ability to make critical decisions. (blaugh.com)
  • Construction workers operate heavy machinery and equipment, and drug testing is necessary to ensure that they are not under the influence of drugs or alcohol while on the job, which can lead to accidents and injuries. (blaugh.com)
  • The tests help to ensure that these employees are not under the influence of drugs or alcohol while working with sensitive equipment or materials. (blaugh.com)
  • In addition, the tests help to ensure that employees are not under the influence of drugs or alcohol, which can impact their ability to make critical decisions related to data security. (blaugh.com)
  • The tests help to ensure that drivers are not under the influence of drugs or alcohol while on the road. (blaugh.com)
  • The tests help to ensure that these employees are not under the influence of drugs or alcohol while administering medications or providing care to patients. (blaugh.com)
  • In addition, the tests help to ensure that these employees are not under the influence of drugs or alcohol while performing their duties. (blaugh.com)
  • The workforce DuPont describes is virtually mandated to chemically decompress from their jobs or lives using alcohol as the drug of choice, as if hangovers or alcoholism can’t affect job performance. (drugwarrant.com)
  • and more vigorous controls on alcohol and drug use in this industry. (cdc.gov)
  • Public Use File Documentation, National Health Interview Survey of Drug and Alcohol Use, 1991 (machine readable data file and documentation), National Center for Health Statistics, Hyattsville, Maryland. (cdc.gov)
  • 1. The 1991 NHIS of Drug and Alcohol Use (NHIS-DAU) data were obtained from a self-administered questionnaire, given to all special topic sample persons 18-44 years of age. (cdc.gov)
  • 5. Comparison of sociodemographic characteristics of respondents and non- respondents indicated women were more likely than men to respond to the drug questionnaire: 74.3 percent of men and 82.5 percent of women who were identified as sample persons eligible for the NHIS of Drug and Alcohol Use (NHIS-DAU) responded to all or part of the NHIS-DAU. (cdc.gov)
  • Mutual regulatory recognition can help drugs cross boundaries without complex processes," said R. K. Agarwal, President, Bulk Drug Manufacturers' Association (BDMA), in a discussion on industry expectations from regulators at the iPHEX and Global Regulators Conclave here. (thehindubusinessline.com)
  • This proposal is unworkable and why the Trucking Alliance is pursuing regulatory and legislative avenues to make sure hair tests are recognized and can rid the industry of drug impaired truck drivers. (thetrucker.com)
  • A foreign building will be considered GMP-compliant if it's currently determined to be compliant for the applicable activity, category of drugs and dosage form by Health Canada or a trusted regulatory partner. (canada.ca)
  • We assist Chinese drug and device regulatory agencies in training programs on a broad range of topics. (sidley.com)
  • However, launching orphan drugs in India can be challenging due to the complex regulatory landscape, limited healthcare infrastructure and high cost of treatment. (wns.com)
  • Proceedings of the 2nd International Conference of Drug Regulatory Authorities, organized by the Italian Ministry of Health, sponsored by the World Health Organization, April 27-30, 1982, Rome, Italy / edited by Duilio Poggiolini. (who.int)
  • The Ministry of Chemicals and Fertilizers on 12th August 2021 has published the Drugs (Prices Control) Third Amendment Order, 2021 to further amend the Drugs (Prices Control) Order, 2013. (org.in)
  • Additionally, successful commercialization is the key to higher drug uptake, as smaller biotechs generally lack the funds and expertise to reach the targeted population. (247wallst.com)
  • The most importantly, this course assumes some initial curiosity in students wanting to see how computer science and computational models have been used to help people push drug discovery forward. (udemy.com)
  • This course will first go through the history of modern drug discovery with an emphasis on computational approaches including Computer-Aided Drug Discovery (CADD) and Machine Learning (ML). It will introduce to you three grand challenges highly relevant to the field of drug discovery, the prediction of protein structures CASP, drug design resource grand challenge D3R and modeling of protein-drug interactions SAMPL. (udemy.com)
  • Among them, computational models and software used in drug candidate discovery will be introduced more extensively because that's where most of my experience and expertise lie in. (udemy.com)
  • WASHINGTON - The Department of Health and Human Services (HHS) in September published proposed mandatory guidelines for federal workplace drug-testing programs that includes guidelines for hair testing. (thetrucker.com)
  • Using data obtained from the Federal Workplace Drug Testing Programs and HHS-certified laboratories, HHS estimates that 275,000 urine specimens are tested annually by federal agencies. (thetrucker.com)
  • Workplace drug testing has largely been a scam since its beginnings, complete with wholly invented statistics on worker productivity and absenteeism, to the point where it's almost impossible to sort out any actual truth in the claims. (drugwarrant.com)
  • What it's really been about is building a very lucrative drug testing industry that depends on marijuana (since it stays longer in the system) resulting in penalizing people for what they do on their own time, creating a negative employment atmosphere, and doing nothing to create a safer workplace. (drugwarrant.com)
  • This from Wikipedia: "Dr. Dupont personally profits from the workplace drug-testing he advises, via his role at Bensinger, DuPont & Associates. (drugwarrant.com)
  • 1] Workers in the cannabis industry face potential workplace hazards, including exposure to: Bacteria, mold, and other fungi resulting from high humidity. (cdc.gov)
  • The Medicaid and CHIP Payment and Access Commission said that state Medicaid programs could receive lower prescription drug rebates because of how CMS defines value-based payments and calculates best price in the proposed rule. (modernhealthcare.com)
  • Bad medicine : the prescription drug industry in the third world / Milton Silverman, Mia Lydecker, Philip R. Lee. (who.int)
  • This could ultimately affect the profitability of health plans, pharmacy benefit managers and drug manufacturers, according to the report. (pharmatimes.com)
  • The report also raises the often-debated topic of declining R&D productivity in the pharmaceutical industry. (pharmatimes.com)
  • Meanwhile, patent expiries could further decrease revenue by up to 60%, says the report, while growing competition from generic drugs, production of cheap counterfeit drugs from markets such as China and India and the emergence of China as a low-cost manufacturing base are exacerbating the problem. (pharmatimes.com)
  • The findings are contained in a Public Citizen report, Rx R&D Myths: The Case Against the Drug Industrys R&D Scare Card . (citizen.org)
  • Public Citizen based the study on an extensive review of government and industry data and a report obtained through the Freedom of Information Act from the National Institutes of Health (NIH). (citizen.org)
  • Importers are still obligated to report all adverse drug reactions (C.01.016 to C.01.019). (canada.ca)
  • The report features an assessment of business advancement plans, strategy changes, income estimation, industry size, and different industry verticals. (pharmiweb.com)
  • The process is designed to rigorously evaluate the safety and efficacy of drugs before they can be marketed to the public. (worldofdtcmarketing.com)
  • The so-called PBMs have long clawed back a fee from pharmacies weeks or months after they dispense a drug. (thelundreport.org)
  • In the early fall, PBM giant Express Scripts sent out confidential contracts announcing that in 2024 it will pay pharmacies roughly 10% below what they typically pay to buy wholesale brand-name drugs - meaning they could lose money on every prescription they fill, according to two independent pharmacists who received the documents. (thelundreport.org)
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments. (ddw-online.com)
  • The guidelines will allow federal executive branch agencies to collect and test a hair specimen as part of their drug-testing programs, with the limitation that hair specimens be used for pre-employment and random testing. (thetrucker.com)
  • The proposed guidelines require collection of an alternate authorized drug-testing specimen in addition to the hair specimen, either simultaneously (i.e., at the same collection event) or when directed by the medical review officer after review and verification of laboratory-reported results for the hair specimen. (thetrucker.com)
  • HHS is also proposing that an alternate authorized drug-testing specimen be collected (i.e. simultaneously collected or collected and tested at the direction of the medical review officer after verification of a positive hair test result. (thetrucker.com)
  • ABSTRACT A cross-sectional study was conducted to determine the extent and pattern of self- medication among adults, to identify their knowledge and practice concerning the purchased drugs and to calculate prescribing and purchaser care indicators. (who.int)
  • Yet, there remains a strong demand for such specialized skills in the pharmaceutical industry, particularly within drug metabolism/pharmacokinetics (DMPK) departments. (aspetjournals.org)
  • The BMPFG is affiliated with the International Society for the Study of Xenobiotics (ISSX) and was specifically created to promote the exchange of ideas pertaining to topics of current and future interest involving the metabolism of xenobiotics (including drugs). (aspetjournals.org)
  • Finally, the authors stress the importance and continued commitment to training the next generation of biotransformation scientists who are not only experienced in the metabolism of conventional small molecule therapeutics, but are also equipped to tackle emerging challenges associated with new drug discovery modalities including peptides, protein degraders, and antibodies. (aspetjournals.org)
  • Likewise, graduate students who receive their training in medicinal chemistry not only learn the art of organic synthesis as applied to rational design and synthesis of enzyme substrates and inhibitors (or receptor agonists and antagonists) for structure-activity relationship (SAR) analyses, but also gain an appreciation for biochemical screening and drug metabolism through their graduate coursework and potentially hands-on experience in the laboratory. (aspetjournals.org)